Chronic Myeloid Leukemia: What HCPs Need to Know

Ehab Atallah, MD, Medical College of Wisconsin, Milwaukee, WI

Recorded on January 24, 2023

Ehab Attalah, MD
Ehab Atallah, MD
Professor of Medicine
Associate Director, Cancer Service Line
Section Head, Hematologic Malignancies
Division of Hematology and Oncology
Medical College of Wisconsin
Milwaukee, WI
In this episode, Dr. Ken Miller sits down with Dr. Ehab Atallah, from the Medical College of Wisconsin, to discuss chronic myeloid leukemia (CML) including the development of tyrosine kinase inhibitors (TKIs), challenges with adherence to treatment, side effect management, and long-term and late effects, including cardiac toxicities. Dr. Atallah describes the work of the H. Jean Khoury Cure CML Consortium, shares his insights in to transitioning patients off TKIs, experience with his patients living with measurable residual disease, and excitement about the future of CML therapy. Learn more by tuning in today!

Leave a Reply

Your email address will not be published. Required fields are marked *